Global Myomectomy Market Report 2026–2035: Key Forecasts and Growth Areas
Uncover key drivers, emerging technologies, and competitive movements shaping the myomectomy market from 2026–2035 with trusted insights from The Business Research Company
How is the Myomectomy Market size predicted to change over the forecast window of 2026–2035?
The myomectomy market size has demonstrated significant growth over recent years. It is anticipated to increase from $1.62 billion in 2025 to $1.76 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.5%. This historical expansion can be attributed to several factors including the rising prevalence of uterine fibroids, increased awareness regarding fertility preservation options, a general growth in gynecological surgical procedures, the expansion of hospital surgical infrastructure, and the enhanced availability of advanced laparoscopic tools.
The myomectomy market size is anticipated to experience substantial growth in the upcoming years, with projections indicating an increase to $2.41 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.1%. This expansion during the forecast period is propelled by factors such as the greater embrace of robotic gynecologic surgeries, increased capital allocation towards minimally invasive technologies, a surge in demand for patient-focused treatment alternatives, the proliferation of specialized women’s health facilities, and an intensified emphasis on quicker recovery post-surgery. Furthermore, major trends anticipated within this period encompass the widespread adoption of minimally invasive surgical approaches, a rise in the utilization of robotic-assisted myomectomy procedures, an escalating desire for fertility-preserving interventions, the broadening availability of sophisticated surgical instruments, and a heightened commitment to achieving precise surgical results.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20576&type=smp
Which Drivers Are Contributing To The Expansion Of The Myomectomy Market?
The increasing occurrence of uterine conditions is anticipated to drive the expansion of the myomectomy market in the coming years. Uterine disorders encompass a variety of medical issues impacting the uterus, including fibroids, endometriosis, and uterine cancer, which can manifest as pain, unusual bleeding, and difficulty conceiving. The surge in uterine disorder cases stems from factors like heightened awareness, postponement of childbirth, hormonal fluctuations, and evolving lifestyles. Myomectomy serves as a treatment for uterine disorders by surgically excising fibroids, thereby reducing symptoms such as pain, excessive bleeding, and reproductive challenges, all while maintaining the uterus. As an illustration, data from May 2025, provided by Cancer Council Victoria, an Australia-based government organization, indicates that in 2023, 926 women received a diagnosis of uterine cancer. This represented an incidence rate of 22.3 per 100,000 females, comprising 2.4% of all cancer diagnoses and 1.2% of all cancer-related fatalities in 2023, positioning uterine cancer as the 5th most frequently diagnosed cancer among females in that area for the year. Consequently, the rising prevalence of uterine disorders is fueling the expansion of the myomectomy market.
What Segment Categories Are Covered In The Myomectomy Market?
The myomectomy market covered in this report is segmented –
1) By Surgical Approach: Abdominal Myomectomy, Hysteroscopic Myomectomy, Laparoscopic Myomectomy
2) By Product: Laparoscopic Power Morcellators, Harmonic Scalpel, Laparoscopic Sealer, Other Products
3) By End-User: Hospitals And Clinics, Surgical Centers, Other End-Users
Subsegments:
1) By Abdominal Myomectomy: Open Abdominal Myomectomy (Laparotomy), Mini-Laparotomy Myomectomy
2) By Hysteroscopic Myomectomy: Resectoscopic Myomectomy, Non-Resectoscopic Techniques
3) By Laparoscopic Myomectomy: Conventional Laparoscopic Myomectomy, Robotic-Assisted Laparoscopic Myomectomy
Which Competitive Trends Are Impacting The Structure Of The Myomectomy Market?
Leading firms in the myomectomy market are concentrating on creating cutting-edge solutions, such as advanced robotic-assisted surgical systems, to satisfy the growing need for less invasive procedures, greater surgical accuracy, and quicker patient recuperation. These robotic systems represent sophisticated surgical platforms, improving a surgeon’s abilities with high-definition 3D imaging, articulating tools, and exact motion scaling, which marks a considerable advancement compared to conventional open or laparoscopic operations. As an illustration, in March 2023, Intuitive Surgical Inc., a U.S.-based medical technology company, introduced the da Vinci Xi fifth-generation robotic surgical system, an inventive platform specifically developed to aid intricate gynecological procedures, such as myomectomy. This system incorporates advanced imaging, controls built for ergonomic comfort, and multi-quadrant entry, enabling surgeons to conduct accurate dissections while minimizing damage to tissue. Its uses encompass the removal of uterine fibroids, hysterectomies, and other gynecologic operations, resulting in less post-operative discomfort, briefer hospitalizations, and quicker healing for patients.
Which Key Players Are Driving Competition In The Myomectomy Market?
Major companies operating in the myomectomy market are Medtronic plc, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Hologic Inc., CooperSurgical Inc., Teleflex Incorporated, Karl Storz SE & Co. KG, CONMED Corporation, Richard Wolf GmbH, ERBE Elektromedizin GmbH, LiNA Medical ApS, KLS Martin Group, Aspen Surgical, BOWA Medical, Aesculap AG, Mindray Medical International Limited
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/myomectomy-global-market-report
Which Region Currently Holds The Largest Share Of The Myomectomy Market?
North America was the largest region in the myomectomy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myomectomy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Myomectomy Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20576&type=smp
Browse Through More Reports Similar to the Global Myomectomy Market 2026, By The Business Research Company
Urology Surgical Instruments Market Report 2026
https://www.thebusinessresearchcompany.com/report/urology-surgical-instruments-global-market-report
Surgical Stapling Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/surgical-stapling-devices-global-market-report
Powered Surgical Instruments Market Report 2026
https://www.thebusinessresearchcompany.com/report/powered-surgical-instruments-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
